<DOC>
	<DOCNO>NCT00333177</DOCNO>
	<brief_summary>This study determine effectiveness various combination psychosocial therapy risperidone treatment improve work school performance people first-episode schizophrenia .</brief_summary>
	<brief_title>Psychosocial Therapy Risperidone Treatment Work Performance Recent-Onset Schizophrenia</brief_title>
	<detailed_description>Schizophrenia chronic , severe , disable brain disorder . People schizophrenia often experience hallucination , delusion , think disorder , movement disorder . These symptom make difficult maintain job , participate school , keep self-care . Proper treatment first-episode schizophrenia may increase chance control disease progression long-term basis . Antipsychotic medication , risperidone , psychosocial treatment , cognitive enhancement train health behavior training , common , effective treatment schizophrenia . This study determine effectiveness various combination psychosocial therapy risperidone treatment improve work school performance people first-episode schizophrenia . Participants open label study randomly assign receive one follow four combination antipsychotic medication psychosocial treatment : cognitive enhancement training plus oral risperidone ; cognitive enhancement training plus long-acting injectable risperidone ; health behavior training plus oral risperidone ; health behavior train plus long-acting injectable risperidone . Cognitive enhancement training entail 2 hour per week computer-assisted training target improve attention , memory , problem-solving skill . Additionally , participant attend weekly 1-hour group meeting learn apply skill work school situation . Health behavior training involve 3 hour per week relaxation training , nutrition education , physical exercise enhance wellness . Participants assign receive oral risperidone receive medication pill form dosage determine optimal study psychiatrist . Participants assign receive injectable risperidone give one injection every 2 week . Dosages start 25 mg per injection adjust need . Treatment continue 1 year follow dosage stabilization , typically occur 2 3 month follow study entry . For first 6 month , participant assign receive health behavior train attend study visit week participant assign receive cognitive enhancement train attend study visit twice week . For final 6 month , participant attend study visit twice weekly . At visit , participant receive assign psychosocial treatment ; attend group therapy ; meet case manager counsel assessment symptom , work functioning , social functioning ; meet psychiatrist monitor medication response . Additional cognitive health behavior measure take every 6 month assess treatment effectiveness .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnosis schizophrenia , schizoaffective disorder ( depressed type ) , schizophreniform disorder First major episode psychotic symptom occur within 2 year prior study entry Neurological disorder injury ( e.g. , encephalitis , epilepsy , traumatic brain injury ) Mental retardation ( e.g. , premorbid IQ le 70 ) Significant alcohol substance use last 6 month Unable complete research measure English Any condition may make risperidone use medically inadvisable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Schizoaffective Disorder , Depressed Type</keyword>
	<keyword>Schizophreniform Disorder</keyword>
	<keyword>First-Episode Schizophrenia</keyword>
	<keyword>Supported Employment</keyword>
	<keyword>Cognitive Remediation</keyword>
	<keyword>Health Behavior Training</keyword>
	<keyword>Antipsychotic Medication</keyword>
</DOC>